Q4 2023 Atea Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, everyone, and welcome to the Taro Pharmaceuticals Fourth Quarter 2023 financial results and business update conference call. At this time, all participants are in a listen only mode following the formal remarks, we will open the call up for your questions.
I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at ITI. pharmaceuticals. It's Barnes. Please proceed.
Good afternoon, everyone, and welcome to the Taylor Pharmaceuticals Fourth Quarter and Full Year 2023 financial results and business update conference call. Earlier today, we issued a press release which outlines the topics we plan to discuss. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at ir dot karyopharm.com.
With me today from a payer are our Chief Executive Officer and Founder, Dr. Jean-Pierre
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |